Population-based strategy for improving informed decision making about hormone replacement therapy in managed care settings

被引:11
作者
LaCroix, AZ [1 ]
Newton, KM
Buist, DSM
Curry, SJ
Scholes, D
Anderson, LA
Keenan, NL
机构
[1] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA
[2] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA
[3] Univ Washington, Sch Publ Hlth & Community Med, NW Prevent Effectiveness Ctr, Dept Epidemiol, Washington, DC USA
[4] Univ Washington, Sch Publ Hlth & Community Med, NW Prevent Effectiveness Ctr, Dept Hlth Serv, Washington, DC USA
[5] Natl Ctr Chron Dis Prevent & Hlth Promot, Div Adult & Community Hlth, Atlanta, GA USA
关键词
D O I
10.1016/S1049-3867(99)00023-7
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
This report describes a series of studies undertaken at Group Health Cooperative of Puget Sound designed to improve informed decision making about hormone replacement therapy for large populations of women in midlife who are served by managed care organizations. Women aged 45-80 years and their health care providers were the focus of separate studies. Health care systems need to provide access to high-quality provider counseling, continuous support in updating providers on the evolving evidence base, and dearly written, unbiased, tailored information for women based on the accumulated scientific evidence.
引用
收藏
页码:306 / 318
页数:13
相关论文
共 31 条
[1]  
Anderson LA, 1999, MENOPAUSE, V6, P161
[2]  
[Anonymous], 1996, GUID CLIN PREV SERV
[3]  
Buist DSM, 1999, AM J EPIDEMIOL, V149, P275
[4]  
*CDCP, 1999, CDC WOND CENS SYST
[5]   Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures - Results from the fracture intervention trial [J].
Cummings, SR ;
Black, DM ;
Thompson, DE ;
Applegate, WB ;
Barrett-Connor, E ;
Musliner, TA ;
Palermo, L ;
Prineas, R ;
Rubin, SM ;
Scott, JC ;
Vogt, T ;
Wallace, R ;
Yates, AJ ;
LaCroix, AZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (24) :2077-2082
[6]   Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women [J].
Delmas, PD ;
Bjarnason, NH ;
Mitlak, BH ;
Ravoux, AC ;
Shah, AS ;
Huster, WJ ;
Draper, M ;
Christiansen, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (23) :1641-1647
[7]   Differences in providers' beliefs about benefits and risks of hormone replacement therapy in managed care [J].
Exline, JL ;
Siegler, IC ;
Bastian, LA .
JOURNAL OF WOMENS HEALTH, 1998, 7 (07) :879-884
[8]   ESTROGEN AND PROGESTIN THERAPY TO PREVENT OSTEOPOROSIS - ATTITUDES AND PRACTICES OF GENERAL INTERNISTS AND GYNECOLOGISTS [J].
GREENDALE, GA ;
CARLSON, KJ ;
SCHIFF, I .
JOURNAL OF GENERAL INTERNAL MEDICINE, 1990, 5 (06) :464-469
[9]   PHYSICIANS VIEWS ON HORMONE-THERAPY AROUND AND AFTER MENOPAUSE [J].
HEMMINKI, E ;
TOPO, P ;
MALIN, M ;
KANGAS, I .
MATURITAS, 1993, 16 (03) :163-173
[10]  
HolmesRovner M, 1996, AM J PREV MED, V12, P420